Funding
Startup Battlefield award · Biotech

Intero Biosystems wins $100,000 Startup Battlefield award

The equity-free prize recognises its human organoid technology.

By RoundOS Funding desk

Intero Biosystems won TechCrunch’s Startup Battlefield competition on October 15, 2026, receiving a $100,000 equity-free prize.

The Denver company develops miniature human intestinal tissues for preclinical research. Its organoid models help drug developers study compound effects in human tissue.

Funding history

Startup Battlefield award · This round$100K
Pre-seed$2M

Sources

  1. And the winner of Startup Battlefield at Disrupt 2026 is: Intero Biosystemstechcrunch.com · Oct 15, 2026
  2. Startup Battlefield finaliststechcrunch.com · Oct 15, 2026

Similar rounds

All Biotech rounds →
GPN Vaccines

GPN Vaccines develops bacterial vaccines designed to protect against a broader range of strains than conventional serotype-specific vaccines.

$10MPrivate placement · Nov 2, 2026
ALLOX

ALLOX combines high-throughput genetics, experimental biology and AI to find functional sites on proteins and develop targeted small-molecule medicines.

$10.5MSeed · Oct 29, 2026
Dren Bio

Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.

$350MPrivate financing · Oct 29, 2026
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedSeries A+ · Oct 28, 2026

Related